AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7,438	7,073	3,347	6,587	7,284	24,377
Short-Term Investments	73,289	85,698	91,135	57,000	61,500	30,000
Cash & Short-Term Investments	80,727	92,771	94,482	63,587	68,784	54,377
Cash Growth	-12.49%	-1.81%	48.59%	-7.56%	26.50%	217.40%
Accounts Receivable	-	-	-	-	-	4,292
Other Receivables	1,044	1,360	1,634	595.17	255.83	147.07
Receivables	1,044	1,360	1,634	595.17	255.83	4,439
Prepaid Expenses	872.67	51.48	159.56	241.6	125.3	553.87
Other Current Assets	293.5	531.27	350.12	2,304	193.49	25.34
Total Current Assets	82,937	94,714	96,626	66,728	69,359	59,395
Property, Plant & Equipment	1,102	1,046	1,200	1,337	1,337	1,667
Long-Term Investments	12,856	341	999.95	11,000	0	0
Other Intangible Assets	1,092	721.98	476.75	358.16	121.75	113.83
Other Long-Term Assets	354.32	297.45	296.28	279.23	246.39	200.58
Total Assets	98,340	97,120	99,599	79,702	71,065	61,376

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	194.06	129.29	312.18	176.74	150.45	401.88
Short-Term Debt	-	-	2,740	5,472	-	-
Current Portion of Leases	334.19	264.65	264.11	247.12	219.84	204.68
Other Current Liabilities	696.88	147.58	5,166	15,849	1,417	3,439
Total Current Liabilities	1,225	541.52	8,482	21,746	1,787	4,045
Long-Term Leases	196.14	233.34	101.85	184.41	91.42	143.14
Other Long-Term Liabilities	37.97	28.91	26.78	24.28	24.45	22.55
Total Liabilities	1,459	803.77	8,611	21,954	1,903	4,211

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	23,414	23,208	22,436	21,574	10,561	9,180
Additional Paid-In Capital	154,593	151,799	137,481	126,746	135,659	116,365
Retained Earnings	-83,863	-82,078	-72,350	-92,355	-78,226	-69,266
Comprehensive Income & Other	2,736	3,387	3,422	1,782	1,168	887.2
Total Common Equity	96,881	96,316	90,988	57,747	69,162	57,165
Shareholders' Equity	96,881	96,316	90,988	57,747	69,162	57,165
Total Liabilities & Equity	98,340	97,120	99,599	79,702	71,065	61,376

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	530.33	497.99	3,106	5,904	311.26	347.82
Net Cash (Debt)	80,197	92,273	91,377	57,683	68,473	54,030
Net Cash Growth	-9.81%	0.98%	58.41%	-15.76%	26.73%	219.95%
Net Cash Per Share	3465.99	4072.41	4170.27	2702.58	3500.37	6479.89
Filing Date Shares Outstanding	23.36	23.21	22.44	21.57	21.12	8.34
Total Common Shares Outstanding	23.36	23.21	22.44	21.57	21.12	8.34
Working Capital	81,712	94,172	88,144	44,982	67,572	55,350
Book Value Per Share	4147.60	4150.07	4055.51	2676.69	3274.38	6855.98
Tangible Book Value	95,789	95,594	90,511	57,389	69,040	57,052
Tangible Book Value Per Share	4100.86	4118.96	4034.26	2660.09	3268.62	6842.33
Machinery	2,631	2,535	2,493	2,176	2,072	1,908
Construction In Progress	48.8	-	-	-	-	150

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error